Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Reset all filters
01 5Cohance Lifesciences
02 32care4
03 9ANI Pharmaceuticals Inc
04 2Abbott Laboratories
05 5Actavis Inc
06 3AiPing Pharmaceutical Inc
07 2Ajanta Pharma Limited
08 4Alphapharm PTY Ltd
09 2Annora Pharma
10 9Apotex Inc
11 4Arrow Pharmaceuticals
12 1Aspire Lifesciences Pvt Ltd
13 3Avet Pharmaceuticals
14 8BGP Group of Companies
15 2BGP PHARMA ULC
16 5Bionpharma
17 3Chartwell Pharmaceuticals llc
18 2EG SpA
19 2EG Spa
20 5Jazz Pharmaceuticals
21 3Norvium
22 1ORIFARM GROUP AS
23 1Oethmaan Biosims
24 2PH HEALTH
25 2Pharmascience Inc.
26 2STADA Arzneimittel
27 3Sandoz B2B
28 2Smith & Kenner Pharmaceuticals
29 4Solvay Chemicals International S.A
30 3Sun Pharmaceutical Industries Limited
31 3Synthon Pharmaceuticals
32 5Teva Pharmaceutical Industries
33 2Torrent Pharmaceuticals Limited
34 2Unimedic AB
35 3Upsher-Smith Laboratories
36 18Viatris
37 4WAGNER PHARMACEUTICALS PTY LTD
Reset all filters
01 4Antic-calc Tablet, Film Coated
02 14CAPSULE, EXTENDED RELEASE;ORAL
03 2Capsule
04 15Film Coated Tablet
05 8Film-Coated Tablets
06 4Fluvoxamine 100Mg 30 Joined' Oral Use
07 4Fluvoxamine 50Mg 30 Joined' Oral Use
08 1Pellets
09 4TAB
10 8TABLET
11 3TABLET; ORAL
12 48TABLET;ORAL
13 4Tablet
14 20tablet
Reset all filters
01 2Allowed
02 2Approved
03 4Authorized
04 40DISCN
05 6Deregistered
06 3Generic
07 1Originator
08 8Prescription
09 22RX
10 51Blank
Reset all filters
01 2APO-FLUVOXAMINE
02 4APO-Fluvoxamine
03 2DUMIROX
04 4Dumirox
05 2FEVARIN
06 2FLUVOXAMINE EG
07 53FLUVOXAMINE MALEATE
08 4FLUVOXAMINE-WGR
09 2Farin
10 3Faverin 100
11 2Faverin 50
12 10Fevarin
13 1Floxifral
14 1Floxifral junior
15 2Fluvosol
16 2Fluvoxamina Sandoz
17 2Fluvoxamine
18 1Fluvoxamine 100 Oethmaan
19 1Fluvoxamine- Hexal
20 12LUVOX
21 2LUVOX CR
22 4Luvox
23 1Luvox 100
24 2MAVERAL
25 2Maveral
26 2Movox 100
27 2Movox 50
28 2PMS-FLUVOXAMINE
29 2TEVA-FLUVOXAMINE
30 8Blank
Reset all filters
01 20Australia
02 8Canada
03 8India
04 16Italy
05 4Norway
06 4South Africa
07 4Spain
08 8Sweden
09 2Switzerland
10 65USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-28
Application Number : 22033
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-28
Application Number : 22033
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA